Matilde Monteiro-Soares David Russell Edward J Boyko William Jeffcoate

Slides:



Advertisements
Similar presentations
Evidence-based Dental Practice Developing guidelines or clinical recommendations Slide #1 This lecture follows the previous online lecture on evidence.
Advertisements

Diabetic Foot Problems
Protocol Development.
Philip M. Ullrich, Ph.D. Spinal Cord Injury QUERI IRC Philip M. Ullrich, Ph.D. Spinal Cord Injury QUERI IRC Philip M. Ullrich, Ph.D. Spinal Cord Injury.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 12 Measures of Association.
JAMES R. CHRISTINA, DPM DIRECTOR SCIENTIFIC AFFAIRS AMERICAN PODIATRIC MEDICAL ASSOCIATION FOOTCARE AND DIABETES.
Department of Health and Human Services Measuring Clinical Lab Ordering Quality: Theory and Practice Steven M. Asch MD MPH VA, RAND, UCLA April 29, 2005.
Prediction Models in Medicine Clinical Decision Support The Road Ahead Chapter 10.
Guidelines and Guideline Development HINF Medical Methodologies Session 13.
Journal Club Alcohol and Health: Current Evidence March-April 2006.
Journal Club Alcohol and Health: Current Evidence July–August 2004.
INSTITUTIONAL PHARMACY PRACTICE STANDARDS
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U. Evidence-based medicine.
Periodontal Disease Risk Developed by PreViser, Inc. Courtesy PreViser Corporation, all rights reserved.
Drug Development for Diabetic Foot Infections: Lessons Learned
If You Can Measure It, You Can Manage It Measuring Periodontal Status to Manage Periodontal Treatment Courtesy PreViser Corporation, all rights reserved.
Developing Research Proposal Systematic Review Mohammed TA, Omar Ph.D. PT Rehabilitation Health Science.
Critical Appraisal of Clinical Practice Guidelines
IPhVWP Polish Presidency, Warsaw October 6 th 2011 Almath Spooner Irish Medicines Board Monitoring the outcome of risk minimisation activities.
Esiti del trattamento con angioplastica transluminale percutanea (PTA) agli arti inferiori nei pazienti diabetici in trattamento dialitico con ischemia.
The Audit Process Tahera Chaudry March Clinical audit A quality improvement process that seeks to improve patient care and outcomes through systematic.
Systematic Reviews.
PERIPHERAL OCCLUSIVE ARTERIAL DISEASE GEMP I Centre for Health Science Education Station 2.
Challenging Patient: Older Patient with Multiple Co-Morbidities.
If You Can Measure It, You Can Manage It Measuring Periodontal Status to Benefit Your Professional Well-Being.
This material was developed by Oregon Health & Science University, funded by the Department of Health and Human Services, Office of the National Coordinator.
Programme Objectives Analyze the main components of a competency-based qualification system (e.g., Singapore Workforce Skills) Analyze the process and.
Evidence-Based Medicine – Definitions and Applications 1 Component 2 / Unit 5 Health IT Workforce Curriculum Version 1.0 /Fall 2010.
WHO GUIDANCE FOR THE DEVELOPMENT OF EVIDENCE-BASED VACCINE RELATED RECOMMENDATIONS August 2011.
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
Component 1: Introduction to Health Care and Public Health in the U.S. 1.9: Unit 9: The evolution and reform of healthcare in the US 1.9a: Evidence Based.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 17 Clinical Practice Guidelines and Clinical Prediction Rules.
All health care professionals must understand and use the EBP approach to practice Incorporates expertise of clinician and patient’s values and preferences.
Appendix 2 Comparison of screening from age 20 and age 25 Table of harms and benefits.
Evidence-Based Dentistry Presenter’s Name. What does EBD mean?
EBM --- Journal Reading Presenter :黃美琴 Date : 2005/10/27.
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 47 Critiquing Assessments.
Chapter 12 Quantitative Questions and Procedures.
Clinical Quality Improvement: Achieving BP Control
Diabetic Foot Care – helping commissioners and providers to
Patient characteristics Ulcer characteristics
Beckert,  Maria Witte,  Corinna Wicke, 
DIAFORA: a new Diabetic Foot Risk Assessment Tool
Advance Care Planning in dementia Dr Karen Harrison Dening Head of Research & Evaluation Dementia UK GSF 2016.
Documentation in Medical Settings
for Overall Prognosis Workshop Cochrane Colloquium, Seoul
DATA COLLECTION METHODS IN NURSING RESEARCH
Present: Disease Past: Exposure
USING NATIONAL GUIDELINES FOR SCREENING, TREATMENT, AND FOLLOW-UP
National Diabetes Foot Care Audit Hospital Admissions Report
DCD Hope, H Wang, R Anders, P Villa, C Kong
To compare demographic and clinical characteristics of those with and without diabetes that undergo a lower extremity amputation in Glasgow, UK Fiona.
Evidence-Based Practice I: Definition – What is it?
Development of an electronic personal assessment questionnaire to capture the impact of living with a vascular condition: ePAQ-VAS Patrick Phillips, Elizabeth.
Melissa Parker James Madison university
The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection.
11/20/2018 Study Types.
By the completion of this presentation, the participant will be able to:
Table of Contents Why Do We Treat Hypertension? Recommendation 5
pulmonary embolism protocol -- EMB review
Dr. Molly Secor-Turner, PhD, RN, FSAHM Associate Professor
All Wales Diabetic foot 19TH - 20th October 2017
DCD Hope, H Wang, R Anders, P Villa, C Kong
MODERATE Risk 1 RISK FACTOR PRESENT Deformity OR Neuropathy OR Peripheral arterial disease No other risk factors x6 more likely to ulcerate Annual assessment.
From the Evidence Analysis to the Creation of Evidence Based Guidelines 1.
Matilde Monteiro-Soares Anne Rasmussen Anita Raspovic Isabel Sacco
Konstantinos Katsanos Joseph Mills Sigrid Nikol Jim Reekers
Nutrition Interventions to Improve Quality of Care
Presentation transcript:

Matilde Monteiro-Soares David Russell Edward J Boyko William Jeffcoate Joseph Mills Stephan Morbach Fran Game www.iwgdfguidelines.org

Diabetic Foot Ulcers- why do we need to classify? Slides courtesy IWGDF; available at: www.iwgdfguidelines.org Diabetic Foot Ulcers- why do we need to classify? Different causes – predisposition/ delayed healing Different outcomes – healing /amputation Different management strategies– offloading/infection/revascularisation

In which clinical situations would classification be useful? Slides courtesy IWGDF; available at: www.iwgdfguidelines.org In which clinical situations would classification be useful? Communication among health professionals about the characteristics of a diabetic foot ulcer To assess an individual’s prognosis with respect to the outcome of their diabetic foot ulcer To guide management in the specific clinical scenario of a patient with an infected diabetic foot ulcer To aid decision-making as to whether a patient with a diabetic foot ulcer would benefit from revascularisation of the index limb To support regional/national/international audit to allow comparisons between institutions

Methodology Develop our own scoring system Slides courtesy IWGDF; available at: www.iwgdfguidelines.org Methodology Develop our own scoring system Published large clinical cohorts 8 clinical features associated with outcome (healing, amputation, mortality) Patient factors: End stage renal disease Limb factors: Peripheral artery disease; loss of protective sensation Ulcer factors: Area; depth; location (forefoot/hindfoot); number (single/multiple); infection.

Currently published classifications: Quality and recommendations Slides courtesy IWGDF; available at: www.iwgdfguidelines.org Currently published classifications: Quality and recommendations Quality of evidence : (i) presence and number of reliability (inter- observer agreement) studies (ii) internal and external validation studies Strength of recommendations: (i) quality of evidence (ii) complexity and components of the classification (iii) number of 8 clinically important variables included

Slides courtesy IWGDF; available at: www.iwgdfguidelines.org

Slides courtesy IWGDF; available at: www.iwgdfguidelines.org PICO: In individuals with an active DFU, which classification system should be used in communication between health professionals to optimise referral ? Recommendation 1: Use SINBAD classification system for communication between health professionals (GRADE recommendation: Strong; Quality of evidence: Moderate)

Slides courtesy IWGDF; available at: www.iwgdfguidelines.org PICO: In individuals with an active DFU, which classification system should be used in communication between health professionals to optimise referral ? Rationale: simple and quick, no specialist equipment, 6/8 of important clinical measures, validated for healing and amputation, good reliability For communication use individual clinical descriptors rather than total score Recommendation 1: Use SINBAD classification system for communication between health professionals (GRADE recommendation: Strong; Quality of evidence: Moderate)

Slides courtesy IWGDF; available at: www.iwgdfguidelines.org PICO: In individuals with an active DFU, which classification/scoring system should be considered when assessing an individual patient to estimate his/her prognosis ? Recommendation 2: Do not use any of the currently available classification/scoring systems to provide individual patient prognosis (Strong; Weak)

Slides courtesy IWGDF; available at: www.iwgdfguidelines.org PICO: In individuals with an active DFU, can any classification/scoring system aid decision making in specialty areas to improve healing and/or reducing amputation risk? Recommendation 3: In a person with diabetes and an infected foot ulcer, use IDSA/IWGDF classification to characterise and guide infection management (Weak; Moderate) Recommendation 4: In a person with diabetes and a foot ulcer, who is being managed in a setting where appropriate expertise in vascular intervention is available, use WIfI scoring to aid decision making in the assessment of perfusion and likelihood of benefit from revascularisation (Weak; Moderate)

Slides courtesy IWGDF; available at: www.iwgdfguidelines.org

Slides courtesy IWGDF; available at: www.iwgdfguidelines.org

Slides courtesy IWGDF; available at: www.iwgdfguidelines.org Rationale: Both classifications have been validated on multiple occasions for various clinical outcomes with consistent results and presented adequate reliability values. So, the quality of the evidence was considered to be strong. Due to their complexity and limited assessment in different populations and contexts, however, a weak strength of recommendation was given.

Slides courtesy IWGDF; available at: www.iwgdfguidelines.org PICO: In individuals with an active DFU, which classification/scoring system should be considered for regional/national/international audit to allow comparisons between institutions? Rationale: simple and quick, no specialist equipment, 6/8 of important clinical measures, validated for healing and amputation in diverse populations of patients with diabetes and an ulcer of the foot, acceptable by clinicians in UK NDFA (>20,000 patients) Recommendation 5: Use the SINBAD system for any regional/national/international audit to allow comparisons between institutions on the outcomes of patients with diabetes and an ulcer of the foot (Strong; High)

Slides courtesy IWGDF; available at: www.iwgdfguidelines.org Considerations: We were unable to recommend any of the currently available classification/ scoring systems to provide an individual prognosis, which would guide management and could help the patient/family. Future research should be directed to develop and validate a simple reproducible classification system for the prognosis of the individual person with a diabetic foot ulcer, their index limb or their ulcer.   None of the currently validated systems contained all 8 of the important prognostic clinical features identified as part of the review process. Future research should be undertaken to establish whether increasing the complexity of classifications by the addition of features such as ESRD, single/multiple ulcers, more detailed site of ulcers (such as plantar/dorsum) or more detailed measures of limb ischaemia significantly improves the validity of the system to predict the outcome, without compromising reliability or clinical utility. We consider that there may never be a single DFU classification system, since the specification of any classification will depend heavily on its purpose and clinical setting. 

Slides courtesy IWGDF; available at: www.iwgdfguidelines.org Acknowledgments:

Matilde Monteiro-Soares David Russell Edward J Boyko William Jeffcoate Joseph Mills Stephan Morbach Fran Game www.iwgdfguidelines.org